BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

420 related articles for article (PubMed ID: 22052276)

  • 1. A randomized, blinded, bilateral intraindividual, vehicle-controlled trial of the use of photodynamic therapy with 5-aminolevulinic acid and blue light for the treatment of actinic keratoses of the upper extremities.
    Taub AF; Garretson CB
    J Drugs Dermatol; 2011 Sep; 10(9):1049-56. PubMed ID: 22052276
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A multicenter, randomized, vehicle-controlled phase 2 study of blue light photodynamic therapy with aminolevulinic acid HCl 20% topical solution for the treatment of actinic keratoses on the upper extremities: the effect of occlusion during the drug incubation period.
    Schmieder GJ; Huang EY; Jarratt M
    J Drugs Dermatol; 2012 Dec; 11(12):1483-9. PubMed ID: 23377520
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of retinoid pretreatment on outcomes of patients treated by photodynamic therapy for actinic keratosis of the hand and forearm.
    Galitzer BI
    J Drugs Dermatol; 2011 Oct; 10(10):1124-32. PubMed ID: 21968662
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Photodynamic therapy with aminolevulinic acid topical solution and visible blue light in the treatment of multiple actinic keratoses of the face and scalp: investigator-blinded, phase 3, multicenter trials.
    Piacquadio DJ; Chen DM; Farber HF; Fowler JF; Glazer SD; Goodman JJ; Hruza LL; Jeffes EW; Ling MR; Phillips TJ; Rallis TM; Scher RK; Taylor CR; Weinstein GD
    Arch Dermatol; 2004 Jan; 140(1):41-6. PubMed ID: 14732659
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Optimization of photodynamic therapy with a novel self-adhesive 5-aminolaevulinic acid patch: results of two randomized controlled phase III studies.
    Hauschild A; Stockfleth E; Popp G; Borrosch F; Brüning H; Dominicus R; Mensing H; Reinhold U; Reich K; Moor AC; Stocker M; Ortland C; Brunnert M; Szeimies RM
    Br J Dermatol; 2009 May; 160(5):1066-74. PubMed ID: 19222455
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Severe cutaneous reaction to photodynamic therapy with blue light.
    Moore MM; Reyna C; Hope RH
    J Drugs Dermatol; 2011 Sep; 10(9):1057-8. PubMed ID: 22052277
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Temperature-Modulated Photodynamic Therapy for the Treatment of Actinic Keratosis on the Extremities: A One-Year Follow-up Study.
    Willey A; Anderson RR; Sakamoto FH
    Dermatol Surg; 2015 Nov; 41(11):1290-5. PubMed ID: 26445287
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treatment of facial actinic keratoses with aminolevulinic acid photodynamic therapy (ALA-PDT) or ingenol mebutate 0.015% gel with and without prior treatment with ALA-PDT.
    Berman B; Nestor MS; Newburger J; Park H; Swenson N
    J Drugs Dermatol; 2014 Nov; 13(11):1353-6. PubMed ID: 25607702
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intraindividual, right-left comparison of topical 5-aminolevulinic acid photodynamic therapy vs. 5% imiquimod cream for actinic keratoses on the upper extremities.
    Sotiriou E; Apalla Z; Maliamani F; Zaparas N; Panagiotidou D; Ioannides D
    J Eur Acad Dermatol Venereol; 2009 Sep; 23(9):1061-5. PubMed ID: 19470041
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Randomized, double-blind, prospective study to compare topical 5-aminolaevulinic acid methylester with topical 5-aminolaevulinic acid photodynamic therapy for extensive scalp actinic keratosis.
    Moloney FJ; Collins P
    Br J Dermatol; 2007 Jul; 157(1):87-91. PubMed ID: 17501954
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The impact of different fluence rates on pain and clinical outcome in patients with actinic keratoses treated with photodynamic therapy.
    Apalla Z; Sotiriou E; Panagiotidou D; Lefaki I; Goussi C; Ioannides D
    Photodermatol Photoimmunol Photomed; 2011 Aug; 27(4):181-5. PubMed ID: 21729165
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Photodynamic therapy of actinic keratosis with topical 5-aminolevulinic acid. A pilot dose-ranging study.
    Jeffes EW; McCullough JL; Weinstein GD; Fergin PE; Nelson JS; Shull TF; Simpson KR; Bukaty LM; Hoffman WL; Fong NL
    Arch Dermatol; 1997 Jun; 133(6):727-32. PubMed ID: 9197826
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Single vs. fractionated photodynamic therapy for face and scalp actinic keratoses: a randomized, intraindividual comparison trial with 12-month follow-up.
    Sotiriou E; Apalla Z; Chovarda E; Goussi C; Trigoni A; Ioannides D
    J Eur Acad Dermatol Venereol; 2012 Jan; 26(1):36-40. PubMed ID: 21366709
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Photodynamic therapy of actinic keratoses with topical aminolevulinic acid hydrochloride and fluorescent blue light.
    Jeffes EW; McCullough JL; Weinstein GD; Kaplan R; Glazer SD; Taylor JR
    J Am Acad Dermatol; 2001 Jul; 45(1):96-104. PubMed ID: 11423841
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A Randomized, Vehicle-Controlled Phase 3 Study of Aminolevulinic Acid Photodynamic Therapy for the Treatment of Actinic Keratoses on the Upper Extremities.
    Brian Jiang SI; Kempers S; Rich P; Marcus S; Houlihan A; Piacquadio D; Pariser D
    Dermatol Surg; 2019 Jul; 45(7):890-897. PubMed ID: 30640777
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Temperature-modulated photodynamic therapy for the treatment of actinic keratosis on the extremities: a pilot study.
    Willey A; Anderson RR; Sakamoto FH
    Dermatol Surg; 2014 Oct; 40(10):1094-102. PubMed ID: 25207759
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Randomized Vehicle-Controlled Study of Short Drug Incubation Aminolevulinic Acid Photodynamic Therapy for Actinic Keratoses of the Face or Scalp.
    Pariser DM; Houlihan A; Ferdon MB; Berg JE;
    Dermatol Surg; 2016 Mar; 42(3):296-304. PubMed ID: 26863596
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Daylight photodynamic therapy for actinic keratoses: a randomized double-blinded nonsponsored prospective study comparing 5-aminolaevulinic acid nanoemulsion (BF-200) with methyl-5-aminolaevulinate.
    Neittaanmäki-Perttu N; Karppinen TT; Grönroos M; Tani TT; Snellman E
    Br J Dermatol; 2014 Nov; 171(5):1172-80. PubMed ID: 25109244
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Short incubation PDT versus 5-FU in treating actinic keratoses.
    Smith S; Piacquadio D; Morhenn V; Atkin D; Fitzpatrick R
    J Drugs Dermatol; 2003 Dec; 2(6):629-35. PubMed ID: 14711141
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treatment of actinic cheilitis by photodynamic therapy with 5-aminolevulinic acid and blue light activation.
    Zaiac M; Clement A
    J Drugs Dermatol; 2011 Nov; 10(11):1240-5. PubMed ID: 22052302
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.